PRACTICAL ONCOLOGY JOURNAL ›› 2011, Vol. 25 ›› Issue (5): 437-438.doi: 10.3969/j.issn.1002-3070.2011.05.008

Previous Articles     Next Articles

Concurrent chemoradiotherapy with weekly Paclitaxol in advanced breast cancer

MO Xueli,WANG Delin,CAO Yujuan,DU Fang,CAO Feng,SUN Jianhua,LIU Chengwei,HAO Longying   

  1. Department of Medical Oncology,Peking University Shougang Hospital,Beijing 100144
  • Received:2011-05-25 Online:2011-10-28 Published:2014-12-02

Abstract: Objective To investigate the treatment pattern in patients with visceral organ metastatic breast cancer who having symptoms of brain or bone metastasis involved.Method The total dose of whole-brain radiotherapy were 45Gy and 40Gy,respectively.Ther bone radiotherapy were 33Gy and 40Gy,respectively.At the same time,chemotherapy were given with Paclitaxol 80mg/m2,d1、8、15,every 21 days as one cycle.The efficacy was evaluated every 2 cycles of chemotherapy according to WHO standard.Result The Objective efficacy of 4 patients were PR.The constricts symptoms of the CNS and pain of the bone were relieved.TTP of 4 patients were 9、5、6+ and 8.5 months,respectively. Conclusion Treatment pattern of concurrent chemoradiotherapy in visceral organ metastatic patients with having symptoms of brain or bone metastasis result in a effectiveness to reduce symptoms and improve QOL.

Key words: Advanced breast cancer, Concurrent chemoradiotherapy, Chemotherapy, Radiotherapy

CLC Number: